D-0441-2026 Class II Ongoing

Recalled by Fagron Compounding Services — Wichita, KS

FDA drug recall D-0441-2026 was initiated by Fagron Compounding Services on Mar 20, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port The recall status is ongoing. Affected quantity: 16,130 bags.

Recall details

Product Type
Drugs
Report Date
Apr 15, 2026
Initiation Date
Mar 20, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,130 bags

Product description

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01

Reason for recall

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Distribution pattern

Nationwide in the U.S.A.

Code information

Lot: C274-000050858, Exp.:7/6/2026; C274-000051018, Exp.: 7/13/2026; C274-000049194, Exp.: 4/20/2026; C274-000049591, Exp.: 5/9/2026; C274-000049592, Exp.: 5/9/2026; C274-000049823, Exp.: 5/18/2026; C274-000050301, Exp.: 6/8/2026; C274-000050411, Exp.: 6/13/2026; C274-000051056, Exp.:7/18/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0441-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0441-2026. Report a data issue: hello@regdatalab.com.